Anhedonia in Depression: Neurobiological and Genetic Aspects

Unleashing lactoferrin's antidepressant potential through the PI3K/Akt/mTOR pathway in chronic restraint stress rats

“…Other associated symptoms may include difficulty sleeping, changes in appetite, difficulty concentrating, fatigue, and feelings of worthlessness or guilt. 1 According to the World Health Organization, depression affects 264 million people of all ages worldwide. It is expected to become the second leading cause of disability globally, posing a considerable social and economic burden.…”